Friday, November 13, 2015

Low-income Brits agree to be injected with experimental Ebola vaccine for $1160.

NaturalNews) It might seem like a death sentence you wouldn't accept for any amount of money, but some lower-income British citizens appear to believe the risk is worth the reward.
As reported by the UK's Daily Mail, a medical research lab is searching for Brits who will voluntarily agree to be injected with the Ebola virus as part of research into finding a cure for the generally fatal disease.

The research firm, Hammersmith Medical Research, began holding clinical trials at the beginning of November to develop an immunization vaccine that scientists hope will prevent future Ebola infections.

There is currently no known or licensed treatment or vaccine for Ebola, which has killed more than 11,000 people so far in West Africa since the globe's largest outbreak began in a forested region of Guinea in December 2013. The disease managed to spread to the U.S. and elsewhere, but it never became as prevalent or deadly as it has been to West African nations Guinea and Sierra Leone.

The paper noted that the prestigious Oxford University held similar clinical trials involving healthy people who agreed to be injected with a single protein from the Ebola virus in order to trigger an immune response and serum for a potential vaccine.

For the current trial, organizers said they are looking for people in London between the ages of 18 and 65 to take part on the trial, which begins later this month. An advertisement for volunteers placed in The Evening Standard says, "Interested in helping medical research into a vaccine for Ebola virus and being paid for your help? Are you 18-65 years old and in good health? If the answer is YES, then you might be suitable for a study of an Ebola vaccine."

The advertisement goes on to note that there is no current specific cure or vaccine for the disease. It also notes that participants are typically administered blood tests and a full medical evaluation to make sure they are healthy enough for the trial before being given the experimental treatment.

"The study will involve up to 12 short outpatient appointments with participants paid up to £750 for their time," says the paper. £750 is about $1,160.

The paper further noted that an experimental vaccine for Ebola proved "highly effective" during human trials earlier this year in Guinea.

The new study will involve as many as a dozen short outpatient visits and could last as long as a year, says the advertisement.

"You won't catch Ebola if you take part in this study," the advert stresses, although any time a foreign virus is purposely introduced into the body, one would have to think that there is at least some risk of catching that disease. Otherwise, why would people who get flu vaccines get the flu?

Learn more: http://www.naturalnews.com/051956_Ebola_vaccine_human_test_subjects_clinical_trials.html#ixzz3rO8teL00